Bal Pharma

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE083D01012
  • NSEID: BALPHARMA
  • BSEID: 524824
INR
94.00
-1.85 (-1.93%)
BSENSE

Oct 09

BSE+NSE Vol: 20.07 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidated - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
15.92
15.92
15.80
15.69
14.82
14.82
Share Warrants & Outstandings
Total Reserve
66.31
61.49
56.20
48.10
42.87
37.82
Shareholder's Funds
82.23
77.42
72.00
63.79
58.63
53.58
Minority Interest
0.03
-0.01
-0.03
-0.09
-0.13
-0.23
Long-Term Borrowings
31.88
31.40
36.35
30.52
27.01
23.93
Secured Loans
31.88
31.40
36.35
30.52
26.85
23.72
Unsecured Loans
0.00
0.00
0.00
0.00
0.17
0.21
Deferred Tax Assets / Liabilities
-0.80
-0.41
1.55
0.70
0.60
2.63
Other Long Term Liabilities
5.97
1.74
1.83
1.68
4.08
3.56
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
6.20
5.64
5.09
5.07
4.69
4.07
Total Non-Current Liabilities
43.26
38.38
44.81
37.97
36.40
34.19
Current Liabilities
Trade Payables
88.97
81.69
77.46
78.92
65.56
47.17
Other Current Liabilities
31.85
17.67
21.39
29.30
28.60
23.89
Short Term Borrowings
127.63
118.98
103.25
100.48
70.75
80.82
Short Term Provisions
0.78
1.17
0.95
0.64
0.73
0.66
Total Current Liabilities
249.23
219.50
203.06
209.33
165.64
152.53
Total Liabilities
374.74
335.28
319.84
311.01
260.53
240.08
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
175.23
157.26
140.20
127.10
111.45
105.10
Less: Accumulated Depreciation
81.23
70.45
60.68
50.64
44.06
36.52
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
94.00
86.81
79.53
76.46
67.39
68.59
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
7.42
2.79
0.47
0.00
1.61
0.00
Intangible assets under development
0.00
0.00
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Loans & Advances
5.48
6.24
4.94
4.70
5.15
4.96
Other Non Current Assets
5.59
4.57
0.74
1.68
1.81
2.39
Total Non-Current Assets
112.50
100.41
85.68
82.85
75.96
75.93
Current Assets Loans & Advances
Current Investments
2.08
2.47
6.76
0.00
0.00
0.00
Inventories
116.36
103.02
87.81
98.00
74.40
60.39
Sundry Debtors
93.63
92.44
99.62
93.98
75.31
67.20
Cash and Bank
7.21
8.05
13.29
7.61
5.39
3.85
Other Current Assets
14.58
6.99
4.70
3.85
6.18
4.72
Short Term Loans and Advances
28.38
21.90
21.98
24.71
23.29
28.00
Total Current Assets
262.23
234.87
234.16
228.16
184.57
164.15
Net Current Assets (Including Current Investments)
13.01
15.37
31.10
18.82
18.93
11.61
Total Current Assets Excluding Current Investments
260.15
232.40
227.40
228.16
184.57
164.15
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
374.74
335.28
319.84
311.01
260.53
240.08
Contingent Liabilities
5.58
17.10
16.96
16.44
16.25
12.99
Total Debt
159.52
150.38
139.60
131.00
97.76
104.75
Book Value per share (adjusted)
0
48.63
45.56
40.66
38.92
35.52
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Mar 2026 is 6.08% vs 7.72% in Mar 2025

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Mar 2026 is 243.10% vs -4.92% in Mar 2025

stock-summary

Fixed Assets

YoY Growth in year ended Mar 2026 is 13.19% vs 12.00% in Mar 2025

stock-summary

Investments

No Investments in the last few periods;

stock-summary

Current Assets

YoY Growth in year ended Mar 2026 is 11.65% vs 0.30% in Mar 2025

Compare Balance Sheet Results of Bal Pharma
Markets Mojo
Figures in Cr
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
15.92
0
15.92
0.00%
Share Warrants & Outstandings
Total Reserve
66.31
0
66.31
0.00%
Shareholder's Funds
82.23
0
82.23
0.00%
Minority Interest
0.03
0
0.03
0.00%
Long-Term Borrowings
31.88
0
31.88
0.00%
Secured Loans
31.88
0
31.88
0.00%
Unsecured Loans
0.00
0
0.00
0.00%
Deferred Tax Assets / Liabilities
-0.80
0
-0.80
0.00%
Other Long Term Liabilities
5.97
0
5.97
0.00%
Long Term Trade Payables
0.00
0
0.00
0.00%
Long Term Provisions
6.20
0
6.20
0.00%
Total Non-Current Liabilities
43.26
0
43.26
0.00%
Current Liabilities
Trade Payables
88.97
0
88.97
0.00%
Other Current Liabilities
31.85
0
31.85
0.00%
Short Term Borrowings
127.63
0
127.63
0.00%
Short Term Provisions
0.78
0
0.78
0.00%
Total Current Liabilities
249.23
0
249.23
0.00%
Total Liabilities
374.74
0
374.74
0.00%
ASSETS
Non-Current Assets
0.00
0
0.00
0.00%
Gross Block
175.23
0
175.23
0.00%
Less: Accumulated Depreciation
81.23
0
81.23
0.00%
Less : Impairment of Assets
0.00
0
0.00
0.00%
Net Block
94.00
0
94.00
0.00%
Lease Adjustment
0.00
0
0.00
0.00%
Capital Work in Progress
7.42
0
7.42
0.00%
Intangible assets under development
0.00
0
0.00
0.00%
Pre-operative Expenses pending
0.00
0
0.00
0.00%
Assets in transit
0.00
0
0.00
0.00%
Non Current Investments
0.00
0
0.00
0.00%
Long Term Loans & Advances
5.48
0
5.48
0.00%
Other Non Current Assets
5.59
0
5.59
0.00%
Total Non-Current Assets
112.50
0
112.50
0.00%
Current Assets Loans & Advances
Current Investments
2.08
0
2.08
0.00%
Inventories
116.36
0
116.36
0.00%
Sundry Debtors
93.63
0
93.63
0.00%
Cash and Bank
7.21
0
7.21
0.00%
Other Current Assets
14.58
0
14.58
0.00%
Short Term Loans and Advances
28.38
0
28.38
0.00%
Total Current Assets
262.23
0
262.23
0.00%
Net Current Assets (Including Current Investments)
13.01
0
13.01
0.00%
Total Current Assets Excluding Current Investments
260.15
0
260.15
0.00%
Miscellaneous Expenses not written off
0.00
0
0.00
0.00%
Total Assets
374.74
0
374.74
0.00%
Contingent Liabilities
5.58
0
5.58
0.00%
Total Debt
159.52
0
159.52
0.00%
Book Value per share (adjusted)
0.00
0
0.00
0.00%
Annual - Borrowings
Borrowings 159.52 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 6.08% vs 7.72% in Mar 2025

Annual - Other Long Term Liabilities
Other Long Term Liabilities 5.97 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 243.10% vs -4.92% in Mar 2025

Annual - Fixed Assets
Fixed Assets 101.42 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 13.19% vs 12.00% in Mar 2025

Annual - Investments
Markets Mojo
No Investments in the last few periods
stock-summary

No Investments in the last few periods;

Annual - Current Assets
Current Assets 262.23 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 11.65% vs 0.30% in Mar 2025

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther

Name: MOJO Markets Private Limited (Research Entity) (SEBI Registration No. INH000021942) (CIN:U74900MH2015PTC264951)

Registered & Correspondence Address: Benefice Business House, Office No. 3B, 3rd Floor, C.S. 242, Mathuradas Mills Estate, N.M. Joshi Marg, Tulsi Pipe Road, Lower Parel West, Mumbai- 400013

For queries or grievances, please contact us on support.ra@mojomarkets.in, Phone : 022-35121239

"Investments in securities market are subject to market risks. Read all the related documents carefully before investing. Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors."